GlassScriptPhysician profile
Marian U Webb
NPI 1780716209
$4,437.43
in general payments reported to CMS, 2019-2025
16 companies · $775 in 2025
The $775 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $142 · 2021: $685 · 2022: $1,389 · 2023: $249 · 2024: $1,025 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,441.02 | 2021-2024 | Acuvue |
| Alcon Vision LLC | $686.96 | 2024-2025 | Tryptyr, Rocklatan, Rhopressa |
| Coopervision INC. | $450.94 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $247.90 | 2023-2025 | Vyzulta, Miebo |
| Allergan, INC. | $242.40 | 2021-2022 | |
| Abbvie INC. | $197.34 | 2022-2023 | Vuity |
| Optos, INC. | $141.83 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.04 | 2019-2021 | |
| Ocular Therapeutix, INC. | $127.40 | 2024 | Dextenza |
| Sight Sciences, INC. | $124.85 | 2024 | Omni Surgical System |
| Regeneron Healthcare Solutions, INC. | $116.83 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $116.18 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $106.95 | 2022 | |
| Astellas Pharma US INC | $105.76 | 2024 | Izervay |
| Dompe US, INC. | $101.36 | 2024 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $93.67 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marian Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.